TerminatedPhase 4ketamine

Pediatric Ketamine Study for Pain Management

NCT ID

NCT02388321

Target Enrollment

22 participants

Start Date

2015-05-01

Est. Completion

2017-10-14

About This Study

Direct comparison of intranasal sub-dissociative dose ketamine with intranasal fentanyl for the treatment of moderate to severe pain in pediatric patients in the emergency department.

Conditions Studied

Pain

Interventions

•Ketamine
•Fentanyl

Eligibility

Age:3 Years - 17 Years

Healthy Volunteers:No

View full eligibility criteria

Inclusion Criteria:

* Children aged 3-17,
* weighing less than 50kg
* present to the pediatric ED with moderate-severe acute pain (defined as pain greater than or equal to 6/10).
* Treating physician determines the patient to require opioid analgesia.

Exclusion Criteria:

* Children with facial trauma or any abnormal nasal anatomy;
* developmentally delayed children;
* children with head trauma/increased intracranial pressure (ICP);
* children with known allergy to fentanyl or ketamine;
* children who are unable to provide pain scale assessment;
* children with chronic pain of greater than 4 weeks;
* Pregnant females;
* and children with a Glasgow Coma Scale (GCS)\<15.

Study Locations (1)

Maimonides Medical Center

Brooklyn, New York, United States